Ayaka Sako, Michiko Matsuse, Vladimir Saenko, Aya Tanaka, Ryota Otsubo, Michi Morita, Sayaka Kuba, Eijun Nishihara, Keiji Suzuki, Tomoo Ogi, et al. TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma. The Journal of clinical endocrinology and metabolism. 2024
Chikako Senju, Yuka Nakazawa, Taichi Oso, Mayuko Shimada, Kana Kato, Michiko Matsuse, Mariko Tsujimoto, Taro Masaki, Yasushi Miyazaki, Satoshi Fukushima, et al. Deep intronic founder mutations identified in the ERCC4/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum. Proceedings of the National Academy of Sciences of the United States of America. 2023. 120. 27. e2217423120
Mitsuyoshi Hirokawa, Michiko Matsuse, Norisato Mitsutake, Ayana Suzuki, Miyoko Higuchi, Toshitetsu Hayashi, Hiroshi Kamma, Akira Miyauchi, Takashi Akamizu. Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma. Diagnostic Pathology. 2023. 18. 1
Hieu Trong Le, Truong P X Nguyen, Mitsuyoshi Hirokawa, Ryohei Katoh, Norisato Mitsutake, Michiko Matsuse, Ayaka Sako, Tetsuo Kondo, Nilesh Vasan, Young Mi Kim, et al. Primary Thyroid Mucoepidermoid Carcinoma (MEC) Is Clinically, Prognostically, and Molecularly Different from Sclerosing MEC with Eosinophilia: A Multicenter and Integrated Study. Endocrine pathology. 2023. 34. 1. 100-111
Tomomi Kurashige, Mika Shimamura, Koichiro Hamada, Michiko Matsuse, Norisato Mitsutake, Yuji Nagayama. Characterization of metabolic reprogramming by metabolomics in the oncocytic thyroid cancer cell line XTC.UC1. Scientific Reports. 2023. 13. 1. 149